stars 1 stars 2 stars 3

Traxeus Pharma Services was founded in 2015 to deliver high quality, strategic regulatory affairs services and training to life sciences companies. Our founders bring a wealth of experience from the two opposing sides of the regulatory process. They have experience of managing and preparing submissions to European Regulatory Authorities and of evaluating marketing application authorisations at the MHRA in the UK. Our associates are experienced in regulatory affairs or have specific technical or quality expertise. We support product registrations in the Europe and China from generics and reformulations to new molecules and medical devices. Traxeus can help you navigate the regulatory pathways with the regulatory authorities, avoiding unnecessary delays, or worse, having an application rejected. Specifically we can prepare and review your submissions, represent you at meeting with European and Chinese regulatory authorities, and if required act as your agent. Gap analysis of the readiness of dossiers for submission is a key strength of our organisation. In addition, Traxeus can assess your project development plans to determine the most effective regulatory strategy.

Traxeus Pharma Services Questions

The Traxeus Pharma Services annual revenue was $1 million in 2026.

Marc Charron is the Managing Director of Traxeus Pharma Services.

1 people are employed at Traxeus Pharma Services.

The NAICS codes for Traxeus Pharma Services are [325, 32, 3254, 32541].

The SIC codes for Traxeus Pharma Services are [283, 28].

Top Traxeus Pharma Services Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users